Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden. Liv Cathrine Heggebø , Ida Maria Henriksen Borgen , Hillevi Rylander , Cecilie Kiserud , Tonje Haug Nordenmark , Taran Paulsen Hellebust , Morten Egeberg Evensen , Magnus Gustavsson , Christina Ramberg , Mette Sprauten , Henriette Magelssen , Hanne Blakstad , Janani Moorthy , Karin Andersson , Ingela Raunert , Thomas Henry , Cecilie Moe , Carin Granlund , Dorota Goplen , Jorunn Brekke , Tor-Christian Aase Johannessen , Tora Skeidsvoll Solheim , Kirsten Marienhagen , Øyvind Humberset , Per Bergström , Måns Agrup , Ludvig Dahl , Michael Gubanski , Helene Gojon , Carl-Johan Brahme , Isabelle Rydén , Asgeir S Jakola , Einar O Vik-Mo , Hanne C Lie , Lars Asphaug , Maziar Hervani , Ingrid Kristensen , Corina Silvia Rueegg , Inge C Olsen , Rolf J Ledal , Eskil Degsell , Katja Werlenius , Malin Blomstrand , Petter Brandal BMJ Open（2023）
摘要
ClinicalTrials.gov Registry (NCT05190172).
更多 查看译文
关键词
Adult oncology, Head & neck tumours, RADIOTHERAPY
AI 理解论文
溯源树
样例
